Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma

dc.contributor.authorGluud, Maria
dc.contributor.authorPallesen, Emil M.
dc.contributor.authorZeng, Ziao
dc.contributor.authorNamini, Martin R. J.
dc.contributor.authorVadivel, Chella Krishna
dc.contributor.authorGjerdrum
dc.contributor.authorLise Mette Rahbek
dc.contributor.authorYan, Lang
dc.contributor.authorAhmad, Sana
dc.contributor.authorLindahl, Lise M.
dc.contributor.authorBzorek, Michael
dc.contributor.authorKamstrup, Maria R.
dc.contributor.authorDey, Saptaswa
dc.contributor.authorOstrowski, Sisse Rye
dc.contributor.authorSorensen, Erik
dc.contributor.authorRantakari, Pia
dc.contributor.authorBonefeld, Charlotte Menne
dc.contributor.authorGeisler, Carsten
dc.contributor.authorWoetmann, Anders
dc.contributor.authorLahesmaa, Riitta
dc.contributor.authorIversen, Lars
dc.contributor.authorWolf, Peter
dc.contributor.authorLitman, Thomas
dc.contributor.authorBuus, Terkild B.
dc.contributor.authorOdum, Niels
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.converis.publication-id516087552
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/516087552
dc.date.accessioned2026-04-24T17:43:45Z
dc.description.abstract<div><h3>Background</h3><p>Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T-cell lymphoma (CTCL) shares clinical similarities with AD and is also associated with a high prevalence of <em>Staphylococcus aureus</em> (<em>S. aureus</em>) colonisation. However, the mechanisms driving skin barrier damage in CTCL and the contribution of bacteria remain poorly understood.</p><h3>Methods</h3><p>We investigate how the interplay between <em>S. aureus</em> (and staphylococcal enterotoxins (SEs)) and primary malignant- and non-malignant T cells affects keratinocyte expression of skin barrier proteins; in vitro, in an EL4 murine lymphoma model of bacteria-driven tumour progression, and in CTCL patient lesions colonised with SE-producing <em>S. aureus</em> before and after bacterial eradication by antibiotic treatment.</p><h3>Results</h3><p><em>S. aureus</em> and SEs activate malignant and non-malignant T cells to release barrier-repressing cytokines, including IL-4, IL-13, IL-22, and OSM, and JAK-dependent downregulation of filaggrin and loricrin in keratinocytes. In the EL4 model, bacteria-colonised tumour-bearing mice show significant filaggrin loss in tumour-adjacent epidermis, whereas antibiotic-treated mice maintain near-normal expression. Clinically, antibiotic eradication of SE-producing <em>S. aureus</em> partially restores filaggrin and loricrin expression in three of four patients, paralleling reduced inflammatory signalling.<br></p><h3>Conclusions</h3><p>SE-producing <em>S. aureus</em> promotes skin barrier impairment in CTCL through cytokine-driven, JAK-dependent repression of structural proteins in keratinocytes. These findings identify microbial–immune crosstalk as a contributor to CTCL skin pathology and provide mechanistic rationale for strategies targeting <em>S. aureus</em> colonisation as adjunctive therapy in CTCL.</p></div>
dc.identifier.eissn1398-9995
dc.identifier.jour-issn0105-4538
dc.identifier.urihttps://www.utupub.fi/handle/11111/59066
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1111/all.70292
dc.identifier.urnURN:NBN:fi-fe2026042333022
dc.language.isoen
dc.okm.affiliatedauthorRantakari, Pia
dc.okm.affiliatedauthorLahesmaa, Riitta
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWiley-Blackwell
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1111/all.70292
dc.relation.ispartofjournalAllergy
dc.titleStaphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma
dc.year.issued2026

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Allergy - 2026 - Gluud - Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in.pdf
Size:
5.63 MB
Format:
Adobe Portable Document Format